Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 July 2023 | Story NONSINDISO QWABE | Photo Supplied
Buhle Hlatshwayo
Buhle Hlatshwayo has been selected for the 2023 Fulbright Foreign Language Teaching Assistant (FLTA) Programme.

Buhle Hlatshwayo, a master’s student on the UFS Qwaqwa Campus, has been selected for the 2023 Fulbright Foreign Language Teaching Assistant (FLTA) programme. Despite initially doubting herself, she took a leap of faith and applied for the programme, which turned out to be a successful decision. The Fulbright Programme is a prestigious scholarship programme that provides opportunities for international educational exchanges. The programme’s overarching aim is to enhance intercultural relations across more than 160 countries.

Hlatshwayo will be teaching isiZulu at the University of Georgia in Athens, Georgia, for an academic year. She leaves South Africa at the end of July.

Hlatshwayo is currently pursuing her Master of Arts with specialisation in English on the UFS Qwaqwa Campus, where she also completed her undergraduate and honours degrees in the same field. Her research focuses on East African Arab migration narratives to the Global North, with a focus on exploring the legacies of colonialism. She is also a learning facilitator in the same department.

A prestigious opportunity 

A friend and colleague, Mxolisi Mabaso, encouraged her to apply, knowing her desire to explore opportunities abroad. 

“I am still in awe of how this opportunity came about, especially because someone else saw potential in me while I didn’t believe in myself. My good friend pushed me to apply, because he knew I always wanted the opportunity to go abroad. I am thrilled and honoured to be part of this prestigious programme. I am looking forward to experiencing the US culture and ways of being.”

On her love for English, Hlatshwayo said she has always been fond of the subject but never considered it as a potential career path. After completing her undergraduate degree, Dr Kudzayi Ngara, a Senior Lecturer in the Department of English on the Qwaqwa Campus, encouraged her to pursue an honour’s degree in English, which ultimately shaped her academic journey.

Professional and personal growth awaits

While in the US, Hlatshwayo said she is looking forward to immersing herself in American culture and pursuing courses in American studies. She aims to learn more about diverse cultural backgrounds and share her South African heritage and cultural values with the international community. She said this exchange of experiences and ideas will broaden her horizons and contribute to her academic and professional development.

“The opportunities would not present themselves if you were not capable. If you know your goals, seize any opportunity that will enable you to get there. I was not granted this opportunity because I’m smarter than everyone else, but because of how I articulated my genuine motivations with future goals and how the Fulbright programme will help me achieve them,” she said.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept